Archives of Pharmacal Research

, Volume 33, Issue 7, pp 1043–1048 | Cite as

Effects of temperature, pH, and inhibitors on the procoagulant characterization of FIa, a factor X activator from the venom of Daboia russellii siamensis (Myanmar)

  • Huanhuan Sun
  • Haiqing Ma
  • Guangyao He
  • Jiashu Chen
  • Pengxin Qiu
  • Guangmei Yan
Research Articles Drug Actions

Abstract

FIa, a factor X activator, was isolated from the venom of Daboia russellii siamensis (Myanmar) after a series of chromatographic separations. FIa displayed procoagulant activity by shortening plasma recalcification time and converted human factor X (FX) to activated human factor X (FXa) by cleaving the heavy FX chain, possibly at the Arg51-Ile52 peptide. FIa was positive in a glycoprotein staining test, demonstrating that it is a glycoprotein. Optimal temperature and pH values were important for FIa procoagulant activity. Procoagulant activity was maintained above 85% of the initial activity at pH 7.0∼8.0, and showed equally maximum activity at temperatures ranging from 30 to 50°C. In addition, FIa procoagulant activity was completely inhibited by EDTA (5 mM), but not by PMSF (10 mM), suggesting that it is a metalloproteinase.

Key words

Snake venom Daboia russelli siamensis Factor X activator Metalloproteinase 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Amphlett, G. W., Byrne, R., and Castellino, F. J., Cation binding properties of the multiple subforms of RVV-X, the coagulant protein from Vipera russelli. Biochemistry, 21, 125–132 (1982).CrossRefPubMedGoogle Scholar
  2. Braud, S., Bon, C., and Wisner, A., Snake venom proteins acting on hemostasis. Biochimie, 82, 851–859 (2000).CrossRefPubMedGoogle Scholar
  3. Farid, T., Nasser, H., Zaki, K., and El-Asmar, M. F., Low molecular weight factor X activator from Cerastes vipera (Sahara sand viper) venom. Toxicon, 31, 1007–1017 (1993).CrossRefPubMedGoogle Scholar
  4. Farid, T. M., Tu, A. T., and El-Asmar, M. F., Characterization of cerastobin, a thrombin-like enzyme from the venom of Cerastes vipera (Sahara sand viper). Biochemistry, 28, 371–377 (1989).CrossRefPubMedGoogle Scholar
  5. Franssen, J. H., Janssen-Claessen, T., and Van Dieijen, G., Purification and properties of an activating enzyme of blood clotting factor X from the venom of Cerastes cerastes. Biochim. Biophys. Acta, 747, 186–190 (1983).PubMedGoogle Scholar
  6. Gowda, D. C., Jackson, C. M., Kurzban, G. P., Mcphie, P., and Davidson, E. A., Core sugar residues of the N-linked oligosaccharides of Russell’s viper venom factor X-activator maintain functionally active polypeptide structure. Biochemistry, 35, 5833–5837 (1996).CrossRefPubMedGoogle Scholar
  7. Harvey, A. L., Bradley, K. N., Cochran, S. A., Rowan, E. G., Pratt, J. A., Quillfeldt, J. A., and Jerusalinsky, D. A., What can toxins tell us for drug discovery? Toxicon, 36, 1635–1640 (1998).CrossRefPubMedGoogle Scholar
  8. Hofmann, H. and Bon, C., Blood coagulation induced by the venom of Bothrops atrox. 1. Identification, purification, and properties of a prothrombin activator. Biochemistry, 26, 772–780 (1987).CrossRefPubMedGoogle Scholar
  9. Kisiel, W., Hermodson, M. A., and Davie, E. W., Factor X activating enzyme from Russell’s viper venom: isolation and characterization. Biochemistry, 15, 4901–4906 (1976).CrossRefPubMedGoogle Scholar
  10. Koh, D. C., Armugam, A., and Jeyaseelan, K., Snake venom components and their applications in biomedicine. Cell. Mol. Life Sci., 63, 3030–3041 (2006).CrossRefPubMedGoogle Scholar
  11. Laemmli, U. K., Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680–685 (1970).CrossRefPubMedGoogle Scholar
  12. Lu, Q., Clemetson, J. M., and Clemetson, K. J., Snake venoms and hemostasis. J. Thromb. Haemost., 3, 1791–1799 (2005).CrossRefPubMedGoogle Scholar
  13. Marsh, N. A., Snake venoms affecting the haemostatic mechanism-a consideration of their mechanisms, practical applications and biological significance. Blood Coagul. Fibrinolysis, 5, 399–410 (1994).PubMedGoogle Scholar
  14. Matsui, T., Fujimura, Y., and Titani, K., Snake venom proteases affecting hemostasis and thrombosis. Biochim. Biophys. Acta, 1477, 146–156 (2000).PubMedGoogle Scholar
  15. Schiffman, S., Theodor, I., and Rapaport, S. I., Separation from Russell’s viper venom of one fraction reacting with factor X and another reacting with factor V. Biochemistry, 8, 1397–1405 (1969).CrossRefPubMedGoogle Scholar
  16. Sun, H. H., Chen, Q., Lin, X., Chen, J. S., Qiu, P. X., and Yan, G. M., Purification and partial characterizations of coagulant protein FIa from Daboia russelli siamensis (Myanmar) venom. Acta Pharmacol. Sin., 28, 1580–1584 (2007).CrossRefPubMedGoogle Scholar
  17. Tans, G. and Rosing, J., Snake venom activators of factor X: an overview. Haemostasis, 31, 225–233 (2001).PubMedGoogle Scholar
  18. Woodhams, B. J., Wilson, S. E., Xin, B. C., and Hutton, R. A., Differences between the venoms of two sub-species of Russell’s viper: Vipera russelli pulchella and Vipera russelli siamensis. Toxicon, 28, 427–433 (1990).CrossRefPubMedGoogle Scholar
  19. Yamada, D., Sekiya, F., and Morita, T., Prothrombin and factor X activator activities in the venoms of Viperidae snakes. Toxicon, 35, 1581–1589 (1997).CrossRefPubMedGoogle Scholar

Copyright information

© The Pharmaceutical Society of Korea and Springer Netherlands 2010

Authors and Affiliations

  • Huanhuan Sun
    • 1
  • Haiqing Ma
    • 2
  • Guangyao He
    • 3
  • Jiashu Chen
    • 1
  • Pengxin Qiu
    • 1
  • Guangmei Yan
    • 1
  1. 1.Department of Pharmacology, Zhongshan School of MedicineSun Yat-sen UniversityGuangzhouChina
  2. 2.State Key Laboratory of Oncology in Southern China and Department of Experimental ResearchSun Yat-sen University Cancer CenterGuangzhouChina
  3. 3.Department of Biochemistry, Zhongshan School of MedicineSun Yat-sen UniversityGuangzhouChina

Personalised recommendations